Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?
Yu-Hsiang Chou, Szu-Yu Pan, Shuei-Liong Lin
Kidney Res Clin Pract. 2023;42(1):27-38.   Published online 2022 Nov 21     DOI:
Citations to this article as recorded by Crossref logo
Update of pericytes function and their roles in kidney diseases
Yu-Hsiang Chou, Szu-Yu Pan, Hong-Mou Shih, Shuei-Liong Lin
Journal of the Formosan Medical Association.2024; 123(3): 307.     CrossRef
RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis
Yu Zhang, Yiqiong Yang, Xiuxiu Hu, Bizhen Wei, Qian Shen, Chuanbing Shi, Pingsheng Chen
Translational Research.2024; 269: 14.     CrossRef
Recent Update on Acute Kidney Injury-to-Chronic Kidney Disease Transition
Eun Sil Koh, Sungjin Chung
Yonsei Medical Journal.2024; 65(5): 247.     CrossRef
Hypoxic Inducible Factor Stabilization in Pericytes beyond Erythropoietin Production: The Good and the Bad
Dario Troise, Barbara Infante, Silvia Mercuri, Claudia Piccoli, Bengt Lindholm, Giovanni Stallone
Antioxidants.2024; 13(5): 537.     CrossRef
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men
Selina Mäkinen, Sreesha Sree, Tuulia Ala-Nisula, Henric Kultalahti, Peppi Koivunen, Heikki A. Koistinen
Diabetologia.2024;[Epub]     CrossRef
Umbilical cord mesenchymal stem cell; a potential therapy on reducing intimal hyperplasia in rabbit arteriovenous fistula (AVF) model, analysis the expression of HIF-1a, eNOS, and MMP-2
Yopie Afriandi Habibie, Dessy Rakhmawati Emril, Azharuddin Azharuddin, Dedy Syahrizal, Maimun Syukri, Jufriady Ismy, Cynthia Retna Sartika
F1000Research.2023; 12: 1350.     CrossRef